Methods of treating chronic neurogenic inflammation using a modified Clostridial toxin

Details for Australian Patent Application No. 2010289969 (hide)

Owner Allergan, Inc.

Inventors Gaxiola, Gustavo M.; Aguilar, Ivan E.; Paz, Gilberto P.

Agent Davies Collison Cave

Pub. Number AU-A-2010289969

PCT Pub. Number WO2011/028371

Priority 12/548,073 26.08.09 US

Filing date 10 August 2010

Wipo publication date 10 March 2011

International Classifications

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

Event Publications

22 March 2012 PCT application entered the National Phase

  PCT publication WO2011/028371 Priority application(s): WO2011/028371

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010289990-Anodization and polish surface treatment

2010289968-System including access port and applicator tool